Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05737849

A Study to Learn About the Tests Looking for a Gene Mutation in Adults With Lung Cancer in China (ELEGANT)

Conditions: Non-small Cell Lung Cancer (NSCLC)

Sex: All
Ages: 18 Years – N/A
Enrollment: 10800
Sponsor: Takeda

Location: China

Summary

The main aim of this study is to examine the percentage of people with lung cancer who carry a certain gene mutation (epidermal growth factor receptor exon 20 insertions - EGFR ex20ins) and their frequency in Chinese participants with Non-small cell lung cancer (NSCLC) after having been tested for the gene mutation.Data from the participant's electronic medical records at the hospital will be collected.

Eligibility Criteria

Inclusion Criteria:Cohort 1 and 2:1. Participants with a diagnosis of locally advanced or metastatic NSCLC, clinical staging of IIIB-IV.Cohort-1:1. Participants who have received NGS testing and have EGFR ex20ins positive result.Cohort-2:1. Participants who have received NGS testingExclusion Criteria:1. Incomplete information, including key demographic characteristics, clinicopathological characteristics, and genetic testing information.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05737849). StuddyBuddy aggregates publicly available trial information.